PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'From the Neuroimmunology Unit (H.A., K.B., M.C.D.), Department of Pathophysiology (P.V., A.T.), and 1st Department of Intensive Care Medicine (E.M., A.K.), Evangelismos Hospital, Faculty of Medicine, National and Kapodistrian University of Athens; and Department of Immunology and Histocompatibility (N.K.), Laikon University Hospital, Athens, Greece.\', \'From the Neuroimmunology Unit (H.A., K.B., M.C.D.), Department of Pathophysiology (P.V., A.T.), and 1st Department of Intensive Care Medicine (E.M., A.K.), Evangelismos Hospital, Faculty of Medicine, National and Kapodistrian University of Athens; and Department of Immunology and Histocompatibility (N.K.), Laikon University Hospital, Athens, Greece. mdalakas@med.uoa.gr.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • e89310.1212/NXI.0000000000000893
?:hasPublicationType
?:journal
  • Neurology(R) neuroimmunology & neuroinflammation
is ?:pmid of
?:pmid
?:pmid
  • 32978291
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Anti-SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome: Studies in 8 stuporous and comatose patients.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all